Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 8301–8350 of 33113
The employment of Gregg Zegras as Executive Vice President and President, Global Ecommerce at the Company ended, effective June 30, 2024
On June 30, 2024, Adrian Haigh departed from his position as Fennec Pharmaceuticals Inc.’s (the "Company") Chief Operating Officer
In connection with the Merger, at the Effective Time, the following persons are no longer serving on the Company’s board of directors: Jan M. Winston, William J. Foote, Dennis G. Romano and Rick Strandlund.
In connection with the Merger, at the Effective Time, the following persons are no longer serving on the Company’s board of directors: Jan M. Winston, William J. Foote, Dennis G. Romano and Rick Strandlund.
In connection with the Merger, at the Effective Time, the following persons are no longer serving on the Company’s board of directors: Jan M. Winston, William J. Foote, Dennis G. Romano and Rick Strandlund.
In connection with the Merger, at the Effective Time, the following persons are no longer serving on the Company’s board of directors: Jan M. Winston, William J. Foote, Dennis G. Romano and Rick Strandlund.
On June 26, 2024, Mr. Eric D. Mullins resigned as a member of the Board of Directors (the “Board”) of ConocoPhillips.
each of Matthew Franklin, Adam Gazzaley, M.D., Ph.D., Mary Hentges, William “BJ” Jones, Jr., Christine Lemke, W. Edward Martucci II, Ph.D., and John Spinale resigned from the board of directors of the Company.
each of Matthew Franklin, Adam Gazzaley, M.D., Ph.D., Mary Hentges, William “BJ” Jones, Jr., Christine Lemke, W. Edward Martucci II, Ph.D., and John Spinale resigned from the board of directors of the Company.
each of Matthew Franklin, Adam Gazzaley, M.D., Ph.D., Mary Hentges, William “BJ” Jones, Jr., Christine Lemke, W. Edward Martucci II, Ph.D., and John Spinale resigned from the board of directors of the Company.
each of Matthew Franklin, Adam Gazzaley, M.D., Ph.D., Mary Hentges, William “BJ” Jones, Jr., Christine Lemke, W. Edward Martucci II, Ph.D., and John Spinale resigned from the board of directors of the Company.
each of Matthew Franklin, Adam Gazzaley, M.D., Ph.D., Mary Hentges, William “BJ” Jones, Jr., Christine Lemke, W. Edward Martucci II, Ph.D., and John Spinale resigned from the board of directors of the Company.
each of Matthew Franklin, Adam Gazzaley, M.D., Ph.D., Mary Hentges, William “BJ” Jones, Jr., Christine Lemke, W. Edward Martucci II, Ph.D., and John Spinale resigned from the board of directors of the Company.
each of Matthew Franklin, Adam Gazzaley, M.D., Ph.D., Mary Hentges, William “BJ” Jones, Jr., Christine Lemke, W. Edward Martucci II, Ph.D., and John Spinale resigned from the board of directors of the Company.
On June 26, 2024, Miles Gilburne resigned as a director of MCAA.
On June 27, 2024, Jeff Dykan, current Class I director of the Board of Directors (the “Board”) of ReWalk Robotics, Ltd. (the “Company”) and chairperson of the Board, notified the Board that he will retire and not stand for reelection at the Company’s 2024 Annual General Meeting of Shareholders (the “Annual Meeting”).
Ronald J. Kramer and Lynn Mestel resigned from the Board and all committees thereof.
Ronald J. Kramer and Lynn Mestel resigned from the Board and all committees thereof.
David Henshall, Kent Mathy, Alison Dean, Sharon Rowlands, Simon Paris, David Benjamin, Richard D’Amore and Rohit Ghai, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
David Henshall, Kent Mathy, Alison Dean, Sharon Rowlands, Simon Paris, David Benjamin, Richard D’Amore and Rohit Ghai, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
David Henshall, Kent Mathy, Alison Dean, Sharon Rowlands, Simon Paris, David Benjamin, Richard D’Amore and Rohit Ghai, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
David Henshall, Kent Mathy, Alison Dean, Sharon Rowlands, Simon Paris, David Benjamin, Richard D’Amore and Rohit Ghai, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
David Henshall, Kent Mathy, Alison Dean, Sharon Rowlands, Simon Paris, David Benjamin, Richard D’Amore and Rohit Ghai, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
David Henshall, Kent Mathy, Alison Dean, Sharon Rowlands, Simon Paris, David Benjamin, Richard D’Amore and Rohit Ghai, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
David Henshall, Kent Mathy, Alison Dean, Sharon Rowlands, Simon Paris, David Benjamin, Richard D’Amore and Rohit Ghai, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
David Henshall, Kent Mathy, Alison Dean, Sharon Rowlands, Simon Paris, David Benjamin, Richard D’Amore and Rohit Ghai, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
On June 27, 2024, the Board of Directors (the “Board”) of Investcorp Credit Management BDC, Inc. (the “Company”) accepted the resignation of Peter Sattelmair from his position as Chief Financial Officer of the Company, effective July 1, 2024.
Iqbal Arshad notified the Company of his decision to resign as Chief Technology Officer of the Company.
On June 30, 2024, Ms. Chen Franco-Yehuda notified Pluri Inc. (the “Company”) of her resignation from her position as Chief Financial Officer, Treasurer and Secretary of the Company, which will become effective as of September 30, 2024.
the Board and Ms. Kast, a director of the Registrant, agreed that she would not stand for re-election as a director of the Registrant at its 2024 annual meeting of shareholders.
Mr. Joshua Ballard resigned from his position as Energy Recovery, Inc.’s (the “Company”) Chief Financial Officer, effective June 30, 2024.
Dennis Ackerman, President of the Company's Bel Power Solutions and Protection segment and the Company's Vice President of Operations, will retire from the Company effective July 31, 2024.
On June 30, 2024, William Horne resigned as member of the Board of Directors of Innoveren Scientific, Inc. (the “Company”).
Mr. Schoening will retire upon Mr. Fraser’s joining the Company, but is expected to remain a consultant for the Company for a period after his retirement.
On June 30, 2024, Grzegorz (Greg) Czajkowski, EVP, Engineering and Support of Snowflake Inc. (the “ Company ”), notified the Company of his decision to resign effective July 19, 2024 to pursue another opportunity.
On June 27, 2024, Stephanie Poe, Chief Financial Officer, Secretary and Treasurer of Smith-Midland Corporation (the “Company”), notified the Company of her decision to resign from her positions with the Company, effective July 17, 2024.
On July 1, 2024, Jerry Salinas notified Cullen Frost Bankers, Inc. (the “Company”) of his intention to retire as Executive Vice President, Chief Financial Officer and Chief Accounting Officer of the Company and Frost Bank effective as of December 31, 2024.
On June 30, 2024, John W. Gildea and Mitchell I. Quain resigned from the Board of Directors (the “Board”) of Star Equity Holdings, Inc. (the “Company”) and all committees of the Board effective as of such date.
On June 30, 2024, John W. Gildea and Mitchell I. Quain resigned from the Board of Directors (the “Board”) of Star Equity Holdings, Inc. (the “Company”) and all committees of the Board effective as of such date.
On June 28, 2024, April Chapman submitted correspondence stating her desire to resign her board position due to other commitments.
Sunil M. Doshi, the Chief Financial Officer (principal financial and accounting officer) (“CFO”) and Treasurer of Fossil Group, Inc. (the “Company”), notified the Company of his intent to resign from the Company, effective July 19, 2024.
on June 27, 2024, Brently G. Baxter notified the Company that he will resign as the Company’s vice president and chief accounting officer effective July 31, 2024.
On June 28, 2024, Ms. Donna Shiroma, the Company’s General Counsel, Compliance Officer and Corporate Secretary, notified AVITA Medical, Inc. (the "Company") of her retirement effective immediately.
On June 26, 2024, Ted Davis, a member of the Board of Directors of Alpha Teknova, Inc. (the “Company”), notified the Company of his intention to retire from the Company’s Board of Directors (the “Board”).
On June 30, 2024, Tim Kutzkey, Ph.D. notified Surrozen, Inc. of his resignation as a member of our board of directors and from all committees of the board of directors on which he served, effective as of June 30, 2024.
Wendy Becker informed Logitech of her decision not to stand for re-election to the Board next year at the Company’s 2025 AGM (assuming Ms. Becker’s re-election at the 2024 AGM).
Patrick Aebischer will not stand for re-election to the board of directors (the “Board”) at the Company’s 2024 Annual General Meeting (the “AGM”), when his current term ends, due to the Company's limits on board service, and not due to any disagreement relating to Logitech’s operations, policies or practices.
Dominick Zarcone retired as the Company’s President and Chief Executive Officer effective June 30, 2024.
Mr. Stone will replace Mr. Michael Schifsky, the interim chief financial officer.
On June 26, 2024, each of Regina Hodits, Ph.D. and Björn Odlander, M.D., Ph.D. notified Carisma Therapeutics Inc. (the “Company”) of their respective decisions to resign from the Company’s board of directors, effective June 30, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.